Innopsys this month will launch a new microarray scanner to meet the needs for higher-resolution imaging of the high-density chips recently released by Agilent Technologies and Roche NimbleGen, according to the Carbonne, France-based firm’s CEO.
 
Stephane Le Brun told BioArray News last week that Innopsys is set to debut the InnoScan 900, a 1-micron resolution system that is the first new system launched by the company since it rolled out the InnoScan 700, a 3-micron resolution system, in 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.